In July 2007, I posted about a very strangely designed study that claimed to show Abilify was an effective treatment for depression when added to anti...
A recent study in the Journal of Clinical Psychopharmacology found that aripiprazole (Abilify) offered no benefit over placebo in treating biploar dep...
There have been many interesting posts written about how data regarding Zetia were buried for quite some time. One of the main storylines in this sag...
A recent report in the St. Petersburg Times has indicated that between 20-26% of atypical antipsychotic prescriptions are for elderly people. The dru...
A trial has recently appeared in the American Journal of Geriatric Psychiatry. This study claims that aripiprazole (Abilify) is safe and effective in...
In a decision that may fan the debate over the use of powerful psychiatric medicines in children, the FDA gave Bristol-Myers Squibb the go-ahead to se...
In a Bloomberg report, it was noted that:Johnson & Johnson cut costs as it faces generic competition to its best-selling prescription drug, the antips...
Eli Lilly has been dogged by concerns about the safety of its drug Zyprexa, which is approved to treat schizophrenia and bipolar disorder.This morning...
Worried about data being hidden in clinical trials, with negative data regarding a drug's safety and/or efficacy being buried? Worry no longer. At l...
Subscribe
.gif)
achoo! The Blog
Dr. Weil's Healthy Living
World of Psychology